Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated 18F-FDG PET/CT

Lung Cancer

Volumn 65, Issue 2, 2009, Pages 180-186

  Chun, Eun Ju ^a   Lee, Hyun Ju ^b   Kang, Won Jun ^c   Kim, Kwang Gi ^d   Goo, Jin Mo ^b   Park, Chang Min ^b   Lee, Chang Hyun ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

18F FDG; GGN; GGO; Ground glass nodule; Ground glass opacity; PET CT; Solitary pulmonary nodules

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG FIBROSIS; LUNG INFILTRATE; LUNG METASTASIS; LUNG NODULE; LYMPHOMA; MALE; NORMAL VALUE; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67449162073     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.11.015     Document Type: Article

References (24)

1. Gould M.K., Maclean C.C., Kuschner W.G., Rydzak C.E., and Owens D.K. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285 (2001) 914-924
2. Kim S.K., Allen-Auerbach M., Goldin J., Fueger B.J., Dahlbom M., Brown M., et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 48 (2007) 214-220
3. Kubota K. Changing pattern of lung cancer and its imaging: (201)Tl SPECT versus [(18)F]FDG PET. J Nucl Med 42 (2001) 1497-1498
4. Henschke C.I., Yankelevitz D.F., Mirtcheva R., McGuinness G., McCauley D., Miettinen O.S., and ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 178 (2002) 1053-1057
5. Kim B.T., Kim Y., Lee K.S., Yoon S.B., Cheon E.M., Kwon O.J., et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 170 (1998) 935-939
6. Chang J.M., Lee H.J., Goo J.M., Lee H.Y., Lee J.J., Chung J.K., et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol 7 (2006) 57-69
7. Kim T.J., Lee K.W., Kim H.Y., Lee J.H., Kim E.A., Kim S.K., et al. Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases. Korean J Radiol 6 (2005) 208-213
8. Nomori H., Ohtsuka T., Naruke T., and Suemasu K. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness. J Thorac Cardiovasc Surg 126 (2003) 1584-1589
9. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 45 (2004) 19-27
10. Patz Jr. E.F., Lowe V.J., Hoffman J.M., Paine S.S., Burrowes P., Coleman R.E., et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188 (1993) 487-490
11. Coleman R.E. PET in lung cancer. J Nucl Med 40 (1999) 814-820
12. 18F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 47 (2006) 426-431
13. Lowe V.J., Fletcher J.W., Gobar L., Lawson M., Kirchner P., Valk P., et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16 (1998) 1075-1084
14. Jones H.A., Clark R.J., Rhodes C.G., Schofield J.B., Krausz T., Haslett C., et al. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 149 (1994) 1635-1639
15. Imdahl A., Jenkner S., Brink I., Nitzsche E., Stoelben E., Moser E., et al. Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions. Eur J Cardiothorac Surg 20 (2001) 324-329
16. 18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30 (2003) 267-273
17. Higashi K., Ueda Y., Seki H., Yuasa K., Oguchi M., Noguchi T., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39 (1998) 1016-1020
18. Kuriyama K., Seto M., Kasugai T., Higashiyama M., Kido S., Sawai Y., et al. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol 173 (1999) 465-469
19. Berger K.L., Nicholson S.A., Dehdashti F., and Siegel B.A. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 174 (2000) 1005-1008
20. Koss M.N., Hochholzer L., Nichols P.W., Wehunt W.D., and Lazarus A.A. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol 14 (1983) 1024-1038
21. Dewan N.A., Gupta N.C., Redepenning L.S., Phalen J.J., and Frick M.P. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 104 (1993) 997-1002
22. Townsend D.W., Carney J.P., Yap J.T., and Hall N.C. PET/CT today and tomorrow. J Nucl Med 45 Suppl. 1 (2004) 4S-14S
23. Lee H.J., Goo J.M., Lee C.H., Yoo C.G., Kim Y.T., and Im J.G. Nodular ground-glass opacities on thin-section CT: size change during follow-up and pathological results. Korean J Radiol 8 (2007) 22-31
24. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417